Samsung Biologics’ Plant 4 in Incheon / Courtesy of Samsung Biologics
By Nam Hyun-woo
Samsung Biologics introduced on Tuesday that it obtained certification from a worldwide security certification firm for its efforts to scale back landfill waste, marking the primary such occasion amongst Korean bio and pharmaceutical companies.
International security agency Underwriters Laboratories, the certification firm, granted a Zero Waste to Landfill certification to Samsung Biologics, which relies in Songdo, Incheon, for recording an 85.4 p.c landfill waste diversion charge in 2023, the corporate mentioned.
Zero Waste to Landfill is a waste diversion validation program that evaluates the landfill waste diversion charges of organizations and grants completely different designations — platinum for one hundred pc, gold for 95 to 99 p.c, silver for 90 to 94 p.c and licensed for these reaching over 80 p.c.
Samsung Biologics mentioned the certification is important as a result of waste recycling is comparatively tough for biopharmaceutical companies, which must incinerate medical waste whereas utilizing numerous supplies in small portions.
Samsung Biologics’ Inexperienced Heart / Courtesy of Samsung Biologics
Final yr, Samsung Biologics established a 1,815 square-meter recycling unit known as Inexperienced Heart to course of common and designated waste individually. This yr, the corporate improved its waste recycling charge by individually amassing artificial resin waste and natural solvent waste, and has been recycling the previous which initially was incinerated.
“Samsung Biologics turned the primary firm in Korea to win the certification due to its top-tier waste administration system,” Samsung Biologics Vice President Park Se-gang mentioned.
“We’ll proceed to strengthen our waste administration and purchase increased designations.”
Samsung Biologics additionally confirmed enhancements in its earnings for the third quarter of this yr. Earlier this month, the corporate posted 1.19 trillion gained ($859 million) in income and 338.6 billion gained in working revenue. The gross sales grew 15 p.c year-on-year and the working revenue additionally inched up by 6 p.c year-on-year. It was the primary time that the corporate logged quarterly gross sales surpassing 1 trillion gained.
